Pulmonary hypertension (PH) risk grows over time for patients with narrowing of the aorta, the body's biggest blood vessel, ...

For columnist Anna Jeter, who's now post-transplant, protecting her health during the winter in Minnesota can be challenging ...

Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...

Tenax Therapeutics said it extended Phase 3 clinical development of PH treatment TNX-103, an oral form of levosimendan.

Insulin resistance correlates with disease severity in CTEPH, and an indicator may help predict clinical worsening in ...

Inhibiting the AURKB enzyme significantly improves multiple measures of blood flow in rats with pulmonary arterial ...

Cuts to federal budgets have the rare disease community on edge. Columnist Jen Cueva calls on us to unite for our future.

Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...

Anna L. Jeter is an artist and writer living in Excelsior, Minnesota, with her parents and her sweet mini goldendoodle, Luna. Anna was diagnosed with pulmonary hypertension in 1999 at the age of 4.